REFERENCES
- Chadban SJ, Briganti EM, Kerr PG, Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003;14:S131–S138.
- Chen N, Wang W, Huang Y, Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant. 2009;24:2117–2123.
- Coresh J, Selvin E, Stevens LA, Prevalence of chronic kidney disease in the United States. J Am Med Assoc. 2007;298:2038–2047.
- Hallan SI, Coresh J, Astor BC, International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–2284.
- El Nahas M. The global challenge of chronic kidney disease. Kidney Int. 2005;68:2918–2929.
- Go AS, Chertow GM, Fan D, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305.
- Afolabi MO, Abioye-Kuteyi EA, Arogundade FA, Prevalence of chronic kidney disease in a Nigerian family practice population. South African Family Practice. 2009;51:132–137.
- Sumaili EK, Krzesinski JM, Zinga CV, Prevalence of chronic kidney disease in Kinshasa: Results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant. 2009;24:117–122.
- Plange-Rhule J, Phillips R, Acheampong JW, Hypertension and renal failure in Kumasi, Ghana. J Hum Hypertens. 1999;13:37–40.
- Lengani A, Laville M, Serme D, Renal insufficiency in arterial hypertension in black Africa. Presse Med. 1994;23:788–792.
- Matekole M, Affram K, Lee SJ, Hypertension and end-stage renal failure in tropical Africa. J Hum Hypertens. 1993;7:443–446.
- Cooper R, Rotimi C, Ataman S, The prevalence of hypertension in seven populations of west African origin. Am J Public Health. 1997;87:160–168.
- Amoah AG. Hypertension in Ghana: A cross-sectional community prevalence study in greater Accra. Ethn Dis. 2003;13:310–315.
- Cappuccio FP, Micah FB, Emmett L, Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension. 2004;43:1017–1022.
- Levey AS, Bosch JP, Lewis JB, A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470.
- Levey AS, Coresh J, Balk E, National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139: 137–147.
- Naicker S. End-stage renal disease in sub-Saharan and South Africa. Kidney Int Suppl. 2003;63(suppl. 83):S119–S122.
- Sumaili EK, Cohen EP, Zinga CV, High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol. 2009;10:18.
- Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:S1–S290.
- Amoah AG, Kallen C. Aetiology of heart failure as seen from a National Cardiac Referral Centre in Africa. Cardiology. 2000;93:11–18.
- van Deventer HE, George JA, Paiker JE, Estimating glomerular filtration rate in black South Africans by use of the modification of diet in renal disease and Cockcroft-Gault equations. Clin Chem. 2008;54:1197–1202.
- US Renal Data System. USRDS Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institute of Diabetes and Digestive and Kidney Disease. National Institute of Diabetes and Digestive and Kidney Disease; Bethesda, MD, 2007.
- Xue JL, Eggers PW, Agodoa LY, Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol. 2007;18:1299–1306.
- Freedman BI, Hicks PJ, Bostrom MA, Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int. 2009;75:736–745.
- Kao WH, Klag MJ, Meoni LA, MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 2008;40:1185–1192.
- Kopp JB, Smith MW, Nelson GW, MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008;40:1175–1184.
- Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: A global challenge. Kidney Int Suppl. 2005;68(suppl. 98):S11–S17.
- Hoy WE, Baker PR, Kelly AM, Reducing premature death and renal failure in Australian aboriginals. A community-based cardiovascular and renal protective program. Med J Aust. 2000;172:473–478.